PsA Minimal Disease Activity — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — 5 of 7
The best answer is “5 of 7”. The PsA minimal disease activity (MDA) criteria require meeting 5 of 7 criteria: tender joint count ≤1, swollen joint count ≤1, PASI ≤1 or BSA ≤3%, patient pain VAS ≤15 mm, patient global VAS ≤20 mm, HAQ ≤0.5, and tender entheseal points ≤1. MDA is a validated composite treatment target for PsA that captures multiple disease domains (joints skin entheses function and patient-reported outcomes). Achieving MDA is associated with less radiographic progression and better functional outcomes. The competing options represent related diagnoses, tests or treatments, but they do not match the decisive phenotype, safety constraint or management point in this stem.
Reference: BSR psoriatic arthritis biologic guideline: https://academic.oup.com/rheumatology/article/61/9/e255/6594139